Entropy Neurodynamics
Entropy Neurodynamics is an Australian biotechnology company focused on developing novel therapies for neurological and psychiatric disorders. They leverage innovative approaches in drug development, aiming to address unmet needs in mental health and improve patient outcomes. The company is listed on the ASX and seeks to create value through its research and development pipeline.
Short position
Entropy Neurodynamics (ASX:ENP) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. ENP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Entropy Neurodynamics (ENP) company profile
Profile, insiders and operations
Company
AI-generated research profile of Entropy Neurodynamics
ENP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links